Ideas to Action:

Independent research for global prosperity

CGD Policy Blogs

 

A close-up of some pills

Healthcare Technologies and COVID-19: Speed is Not Always a Good Thing

With a focus on tests, treatments, and a vaccine, we take a look at the emerging global clinical and economic evidence-base underpinning some of these technologies, the mechanisms (mostly global) for financing these commodities, and, finally, the decision-making processes for selecting technologies. This includes identifying the right subpopulations and negotiating a cost-effective tiered price across countries and regions.

A figure showing that the patients with the most critical cases are a small percentage but their case takes most of the resources required.

Strengthening the Basics: Approaches to COVID-19 Care in Low-Resource Settings

This blog focuses on hospital treatment for COVID-19 patients in low-resource-settings, considering what we know about the spectrum of COVID-19 illness and what this tells us about where resources might best be focused in low-resource-settings. As elsewhere, decision makers, global and local, must prioritise resourcing and capacity development for the ward-level care and simple oxygen therapy that most hospitalised COVID-19 patients will need—not the high-end clinical care that may well be impossible to scale-up in time in countries with limited resources.